Based on CD34+ and VEGFR2+ vascular counts in various human breast cancer subtypes, cases were ranked from negative to low (1–5) to intermediate (6–10) to high (>10) VEGFR2+ vessel counts (Fig. 2). The gene discussed is CD34; the disease is breast carcinoma.